Article Details

PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for ...

Retrieved on: 2021-12-28 16:01:30

Tags for this article:

Click the tags to see associated articles and topics

PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for .... View article details on hiswai:

Excerpt

(KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, today announced it has ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up